CACLP - The largest IVD Expo & Conference

Roche to Acquire TIB Molbiol to Expand Infectious Disease Test Portfolio

Industry news | 10 September, 2021 | CACLP


Original from: Genomeweb

Image Credit: Valor


Roche announced on Thursday that it has entered a share purchase agreement to acquire 100 percent of the outstanding shares of the TIB Molbiol Group. 


The deal is expected to close in the fourth quarter of 2021. Financial and other terms were not disclosed.


Roche said in a statement that the acquisition will enhance its portfolio of molecular diagnostic solutions for infectious diseases. TIB Molbiol currently has more than 45 CE-IVD marked tests and more than 100 research use assays that are available on Roche's LightCycler PCR and MagNA Pure sample prep systems, Roche said.


Berlin-based TIB Molbiol also has diagnostic tests for inherited genetic and somatic mutation testing and quantitative assays for hematology and transplantation medicine. 


The companies have collaborated on infectious disease tests for more than 20 years, including developing the first research-use-only SARS-CoV-2 detection test in January 2020, Roche said.


"With this acquisition, we can expand our offering of tests of existing pathogens and our response to emerging pathogens and potential health threats," Thomas Schinecker, CEO of Roche Diagnostics, said in a statement.


Source: Roche to Acquire TIB Molbiol to Expand Infectious Disease Test Portfolio

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference